Organization: Health Canada
Year: 2020
Month: April
Request Number: A-2019-001772
Request Summary: Advise whether the Abbreviated New Drug Submission (ANDS) for liraglutide accepted into review on August 2017 has received either: Notice of Deficiency (NOD); Notice of Non-Compliance (NON); NOD-Withdrawal (NOD-W) or NON-Withdrawal (NON-W).
Disposition: Disclosed in part
Number of pages: 5